![Jeffrey Brill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Brill
Keine laufenden Positionen mehr
Profil
Jeffrey Brill worked as an Associate Director of Clinical Development at Ascenta Therapeutics, Inc. from 2005 to 2017.
Prior to that, he worked as a Principal at Labcorp Drug Development, Inc. and Gemin X Pharmaceuticals US, Inc. Mr. Brill received his undergraduate degree from the University of Delaware.
Ehemalige bekannte Positionen von Jeffrey Brill
| Unternehmen | Position | Ende |
|---|---|---|
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Corporate Officer/Principal | 31.12.2017 |
| COVANCE INC. | Corporate Officer/Principal | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Brill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Health Technology |
